Subscribe to
Alerts
Posts

Category Archive for 'Action Alerts'

On March 31st, the FDA’s Oncologic Drugs Advisory Committee (ODAC) will be meeting to consider FDA approval of Avastin (bevacizumab) as a single-agent treatment for the treatment of previously treated glioblastoma multiforme (GBM).
Al Musella will be attending the meeting to argue for FDA approval of Avastin and is asking for permission to speak on behalf [...]

Read Full Post »

On January 22, 2009 Rep. Barbara Lee (D-CA) introduced HR 653 (formerly HR 7153), The National Childhood Brain Tumor Prevention Network Act of 2009, to the House of Representatives.

Also on January 22, Senators Charles Schumer (D-NY) and David Vitter (R-LA) introduced S.305, the companion bill to HR 653, to the U.S. Senate.

Read Full Post »

On September 26, Rep. Barbara Lee (D-CA) introduced HR 7153, The National Childhood Brain Tumor Prevention Network Act of 2008, to the House of Representatives.

The Bill provides for the establishment of a comprehensive, multi-center collaborative research effort to thoroughly investigate the causes of pediatric brain tumors and identify risk factors.

Read Full Post »

H.R. 154 (and its companion Senate Bill S. 2102), introduced in January 2007, will eliminate the current two-year period for people with life-threatening conditions. For those with other health conditions, the waiting period would be phased out.
This is crucial for people with brain tumors, many of whom are no longer able to work and [...]

Read Full Post »